After building a successful Botox practice for the past 5 years, Nikki is now offering filler treatments.  Areas that get the best results with filler include cheeks, chin, lips, under the eyes and around the mouth and jawline. Whether you choose Nikki or Dr. Arlette for your treatment, first-time filler patients save!  And as always, your consultation will be complimentary.

Ready for Botox?  First-time Botox patients can enjoy this extra saving. Choose your price range.

You can now select from one of three injectors: Dr. Arlette, Nikki or our newest Nurse Injector, Heather, suited to varying price points.

Botox

What exactly is in BOTOX®?

Dr. Arlette has over 30 years experience in his thriving practice in Calgary, Alberta. For the last 20 years he has been utilizing muscle relaxants, like Botox, in his treatments. Our experienced Doctors and staff will perform these cosmetic procedures, and ensure that you have a customized treatment plan, so that you get the best results.

BOTOX® Cosmetic is the only approved treatment to temporarily improve the appearance of both moderate to severe frown lines between the brows and crow’s feet lines in adults.

BOTOX® Cosmetic is one of the most extensively studied medical aesthetic treatments and is approved for cosmetic use in 78 countries.* BOTOX® Cosmetic has a record of experience that aesthetic providers know and trust. And, the safety and efficacy of BOTOX® Cosmetic have been evaluated in both Allergan sponsored clinical trials as well as in 417 peer-reviewed articles in scientific and medical journals.

Real Results

Customized Treament

(403) 216-4685

Call for an appointment. It’s that simple!

To Learn More About Botox

Contact the skincare experts at Total Skincare Centre in Calgary
All content on this page has been sourced from www.botox.com. For more information please visit the official Botox website.
IMPORTANT SAFETY INFORMATION 
Do not take BOTOX® or BOTOX® Cosmetic if you: are allergic to any of the ingredients in BOTOX® (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA); have a skin infection at the planned injection site.
Do not take BOTOX® for the treatment of urinary incontinence if you: have a urinary tract infection (UTI) or cannot empty your bladder on your own and are not routinely catheterizing.
Due to the risk of urinary retention (not being able to empty the bladder), only patients who are willing and able to initiate catheterization post-treatment, if required, should be considered for treatment.
Patients treated for overactive bladder
In clinical trials, 36 of the 552 patients had to self-cathetherize for urinary retention following treatment with BOTOX® compared to 2 of the 542 treated with placebo.
Patients with diabetes mellitus treated with BOTOX® were more likely to develop urinary retention than non-diabetics.
Patients treated for overactive bladder due to neurologic disease
In clinical trials, 30.6% of patients (33/108) who were not using clean intermittent catheterization (CIC) prior to injection, required catheterization for urinary retention following treatment with BOTOX® 200 Units as compared to 6.7% of patients (7/104) treated with placebo. The median duration of post-injection catheterization for these patients treated with BOTOX® 200 Units (n=33) was 289 days (minimum 1 day to maximum 530 days) as compared to a median duration 358 days (minimum 2 days to maximum 379 days) for patients receiving placebo (n=7).
Among patients not using CIC at baseline, those with MS were more likely to require CIC post-injection than those with SCI.

Please see BOTOX® Cosmetic full Product Information including Boxed Warning and Medication Guide.